Search

Author/Creator Hang, Xiaosheng

1. 366 A randomized double-blind placebo-controlled phase III study evaluating perioperative toripalimab combined with platinum-based doublet chemotherapy in resectable stage III NSCLC. (10th December 2020)

Authors:
Wang, Wenxiang; Wu, Lin; Zhang, Wei; Lu, Shun; Fang, Haohui; Yu, Guohua; Zhou, Ming; Xing, Wenqun; Chen, Qixun; Li, Xingya; Yang, Nong; Ye, Minhua; Fang, Wentao; Huang, Yunchao; Liu, Jichun; Tan, Lijie; Hang, Xiaosheng; Zhang, Wengang; Zhang, Liwei; Chen, Jun
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A223
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 366 A randomized double-blind placebo-controlled phase III study evaluating perioperative toripalimab combined with platinum-based doublet chemotherapy in resectable stage III NSCLC. (9th November 2020)

Authors:
Wang, Wenxiang; Wu, Lin; Zhang, Wei; Lu, Shun; Fang, Haohui; Yu, Guohua; Zhou, Ming; Xing, Wenqun; Chen, Qixun; Li, Xingya; Yang, Nong; Ye, Minhua; Fang, Wentao; Huang, Yunchao; Liu, Jichun; Tan, Lijie; Hang, Xiaosheng; Zhang, Wengang; Zhang, Liwei; Chen, Jun
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A391
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗